Polypharmacy, Medication-Related Burden and Antiretroviral Therapy Adherence in People Living with HIV Aged 50 and Above: A Cross-Sectional Study in Hunan, China-Reference-Cited by-同舟云学术

Polypharmacy, Medication-Related Burden and Antiretroviral Therapy Adherence in People Living with HIV Aged 50 and Above: A Cross-Sectional Study in Hunan, China

Published:2022-01 Issue: Volume:Volume 16 Page:41-49
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Zheng Chunyuan,Meng Jingjing,Xiao Xueling,Xie Ying,Zhao Di^ORCID,Wang Honghong^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference42 articles.

1. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

2. UNAIDS. AIDSinfo | UNAIDS Global data on HIV epidemiology and response; 2021.

3. Future challenges for clinical care of an ageing population infected with HIV: a modelling study

4. Epidemiological analyses of regional and age differences of HIV/AIDS prevalence in China, 2004–2016

5. Aging, sex, inflammation, frailty, and CMV and HIV infections

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of viral suppression and medication-related burden among HIV-infected adults in a secondary care facility;Exploratory Research in Clinical and Social Pharmacy;2024-09

2. Factors associated with antiretroviral treatment adherence among people living with HIV in Guangdong Province, China: a cross sectional analysis;BMC Public Health;2024-05-20

3. Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies;AIDS Research and Therapy;2024-03-21

4. Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study;Journal of Antimicrobial Chemotherapy;2024-01-24

5. An overview of multimorbidity and polypharmacy in older people living with HIV;Geriatrics & Gerontology International;2023-11-08